Form D · Pharmaceuticals

Axxess Compounding LLLP

Pacific Palisades, CA · CIK 0001584530

Offering snapshot reported Nov 7, 2014 · SEC filing

Reported sold
$458K
Offering amount: $25M
Investors reported
34
Form D · investor count
Minimum accepted
$5K
Reported outside-investor minimum
First sale
Aug 6, 2013
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$229K$458KAug 16, 2013: $25,000.00Aug 16, 2013Jan 9, 2014: $240,000.00Jan 9, 2014Nov 7, 2014: $457,500.00Nov 7, 2014

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$240,000 → $457,500
  • Reported investors3 → 34

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 7, 2014Amendment$457,500$217,500vs Jan 9, 201434SEC filing
Jan 9, 2014Amendment$240,000$215,000vs Aug 16, 20133SEC filing
Aug 16, 2013Initial$25,000No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-201471

Source: Form D, filed Nov 7, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Francis X Riegler Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
15332 Antioch St Suite 548
Pacific Palisades, CA, 90272